glp 1 dietician GLP-1 Diet GLP-1 Drugs: Food Industry Threat

Anderson, MD, MAS, an assistant professor of medicine from the University of Pittsburgh, clinical trials of several GLP-1 receptor agonists like semaglutide (Wegovy/Ozempic, Novo Nordisk) for weight loss included exclusion criteria of chronic medical and psychiatric conditions. However, [FDA] labeling does not restrict these treatments in these populations, they wrote in JAMA Internal Medicine

Gastrointestinal issues such as nausea, vomiting, diarrhoea, and constipation is common among users

Bruce Zuraw will summarize key clinical considerations that practicing physicians must keep in mind when prescribing preventive therapies developed through clinical trials

A total of 1500cc of fat was removed